| 2GAS | Recombinant SPBN-based RABV variant carrying two copies of the GAS glycoprotein gene |
| Acc | Primary astrocytes from the murine corpus callosum |
| AIF-1 | Allograft inflammatory factor 1 |
| AI | Artificial intelligence |
| ANOVA | Analysis of variance |
| AraC | Cytosine arabinoside |
| AUC | Area under the curve |
| BBB | Blood–brain barrier |
| BSR | Baby hamster kidney (BSR) cell line expressing T7 polymerase |
| C1q | Complement component 1q |
| CCL4 | Chemokine (C-C motif) ligand 4 |
| CD3 | Cluster of differentiation 3 (T-cell marker) |
| cc | Corpus callosum |
| CNS | Central nervous system |
| Ct | Threshold cycle |
| Cx | Neocortex |
| DAMPs | Danger-associated molecular patterns |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DIV | Days in vitro |
| DMEM | Dulbecco’s Modified Eagle Medium |
| DNA | Deoxyribonucleic acid |
| DNase I | Deoxyribonuclease I |
| DOG4 | Highly pathogenic dog-originated rabies virus strain DOG4 |
| DRV4 | Dog rabies virus isolate 4 (original designation of DOG4) |
| d.p.i. | Days post infection |
| FAD | Fluorescent antibody dilution buffer |
| FBS | Fetal bovine serum |
| FFU | Focus-forming unit |
| G | Glycoprotein |
| GAS | RABV G gene carrying the R333E pathogenicity determinant and N194S substitution |
| GFAP | Glial fibrillary acidic protein |
| Hpc | Hippocampus |
| h.p.i. | Hours post infection |
| IC-LD50 | 50% intracerebral lethal dose |
| IFN(-β, -γ) | Interferon (beta, gamma) |
| IL-1β | Interleukin-1 beta |
| i.c. | Intracerebral |
| i.n. | Intranasal |
| L | RNA-dependent RNA polymerase (large protein) |
| LOEWE | Initiative for Excellence in Science and Technology of the state of Hessen |
| M | Matrix protein |
| m.o.i. | Multiplicity of infection |
| mGluR2 | Metabotropic glutamate receptor 2 |
| NA | Neuroblastoma cell line of A/J mouse origin |
| nAChR | Nicotinic acetylcholine receptor |
| NCAM | Neural cell adhesion molecule |
| N | Nucleoprotein |
| P | Phosphoprotein |
| PBS | Phosphate-buffered saline |
| PCR | Polymerase chain reaction |
| PEP | Postexposure prophylaxis |
| qPCR | Quantitative polymerase chain reaction |
| RABV | Rabies virus |
| RABVG | Rabies virus genome |
| RNA | Ribonucleic acid |
| RNA-seq | RNA sequencing |
| RNP | Ribonucleoprotein |
| RPMI | Roswell Park Memorial Institute medium |
| RT | Reverse transcription |
| RT-PCR | Reverse transcription polymerase chain reaction |
| RT-qPCR | Reverse transcription–quantitative polymerase chain reaction |
| SAD B19 | Street Alabama Dufferin B19 rabies virus strain |
| Sbt | Sorbitol |
| SELP | P-selectin (endothelial activation molecule) |
| SEM | Standard error of the mean |
| SFM | Serum-free medium (OptiPro SFM) |
| SPBN | Recombinant derivative of SAD B19 with pseudogene deleted and modified G locus |
| SPBNGA | SPBN variant carrying R333E mutation in G (“GA”) |
| SPBNGAK | SPBN variant carrying N194K and R333E mutations in G (“GAK”) |
| SPBNGAS | SPBN variant carrying N194S and R333E mutations in G (“GAS”) |
| SVZ | Subventricular zone |
| VNAs | Virus-neutralizing antibodies |
| WHO | World Health Organization |